Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
Trial details
- Registry ID
- NCT02952508
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as CLR 131; I-131-CLR1404
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromNCT02952508 | CLRB | Phase 2 | Active not recruiting | 2026-06-22Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |